1.毕增祺，谌贻璞，李学旺，等.IgA肾病40例临床病理分析.中华内科杂志，1984，23（3）：136-140.

2.师素芳，张宏，邹万忠，等.新型IgA肾病病理分型解读.中华肾脏病杂志，2010，26（7）：489-492.

3.张宏.IgA肾病//王海燕.肾脏病临床概览.北京：北京大学医学出版社，2010：141-147.

4.吕继成，张宏，陈育青，等.家族性IgA肾病—777例中国IgA肾病回顾性调查分析.中华肾脏病杂志，2004，20 （1）：5-7.

5. Geddes CC，Rauta V，Gronhagen-Riska C，et al.A tricontinental view of IgA nephropathy.Nephrol Dial Transplant，2003，18（8）：1541-1548.

6. Li LS，Liu ZH.Epidemiologic data of renal diseases from a single unit in China：analysis based on 13，519 renal biopsies.Kidney Int，2004，66（3）：920-923.

7. Robert JW，Bruce AJ. IgA Nephropathy. N Engl J Med，2013，368：2402-2414.

8. Boyd JK，Cheung CK，Molyneux K，et al.An update on the pathogenesis and treatment of IgA nephropathy. Kidney Int，2012，81：833-843.

9. Lai KN.Pathogenesis of IgA nephropathy.Nat Rev Nephrol，2012，8：275-283.

10. Novak J，Julian BA，Mestecky J，et al. Glycosylation of IgA1 and pathogenesis of IgA nephropathy.Semin Immunopathol，2012，34：365-382.

11. Vuong MT，Hahn ZM，Lundberg S，et al.Association of soluble CD89 levels with disease progression but not susceptibility in IgA nephropathy. Kidney Int，2010，78：1281-1287.

12. Coppo R，Is a legacy effect possible in IgA nephropathy？Nephrol Dial Transplant，2013，28（7）：1657-1662.

13. Lee SM，Rao VM，Franklin WA，et al.IgA nephropathy：morphologic predictors of progressive renal disease.Hum Pathol，1982，13（4）：314-322.

14. Haas M.Histologic subclassification of IgA nephropathy：a clinicopathologic study of 244 cases.Am J Kidney Dis，1997，29（6）：829-842.

15. Cattran DC，Coppo R，Cook HT，et al.The Oxford classification of IgA nephropathy：rationale，clinicopathological correlations，and classification.Kidney Int，2009，76（5）：534-545.

16. Hirano K，Kawamura T，Tsuboi N，et al.The predictive value of attenuated proteinuria at 1 year after steroid therapy for renal survival in patients with IgA nephropathy.Clin Exp Nephrol，2013，17（4）：555-562.

17. Kiryluk K，Julian BA，Wyatt RJ，et al.Genetic studies of IgA nephropathy：past，present，and future.Pediatr Nephrol，2010，25：2257-2268.

18. Kidney Disease：Improving Global Outcomes（KDIGO）Glomerulonephritis Work Group.KDIGO clinical practice guideline for glomerulonephritis.Kidney Int Suppl，2012，2：139-274.

19. Komatsu H，Fujimoto S，Hara S，et al.Effect of tonsillectomy plus steroid pulse therapy on clinical remission of IgA nephropathy：A controlled study.Clin J Am Soc Nephrol，2008，3：1301-1307.

20. Kennoki T，Ishida H，Yamaguchi Y，et al.Proteinuria-reducing effects of tonsillectomy alone in IgA nephropathy recurring after kidney transplantation. Transplantation，2009，88（7）：935-941.

21. Wang Y，Chen J，Chen Y，et al.A meta-analysis of the clinical remission rate and long-term efficacy of tonsillectomy in patients with IgA nephropathy. Nephrol Dial Transplant，2011，26：1923-1931.

22. Lai KN，Leung JC，Chan LY，et al.Activation of podocytes by mesangial-derived TNF-alpha：glomerulo-podocytic communication in IgA nephropathy.Am J Physiol Renal Physiol，2008，294：F945-F955.

23. Lv JC，Xu DM，Vlado P，et al.Corticosteroid therapy in IgA nephropathy. J Am Soc Nephrol，2012，23：1108-1116.

24. Lv J，Zhang H，Chen Y，et al. Combination therapy of prednisone and ACE inhibitor versus ACE-inhibitor therapy alone in patients with IgA nephropathy：A randomized controlled trial.Am J KidneyDis，2009，53：26-32.

25. Manno C，Torres DD，Rossini M，et al.Randomized controlled clinical trial of corticosteroids plus ACE-inhibitors with long-term follow-up in proteinuric IgA nephropathy. Nephrol Dial Transplant，2009，24：3694-3701.

26. Shima Y，Nakanishi K，Kamei K，et al.Disappearance of glomerular IgA deposits in childhood IgA nephropathy showing diffuse mesangial proliferation after 2 years of combination/prednisolone therapy. Nephrol Dial Transplant，2011，26（1）：163-169.

27. Suzuki K，Honda K，Tanabe K，et al.Incidence of latent mesangial IgA deposition in renal allograft donors in Japan.Kidney Int，2003，63（6）：2286-2294.

28. Takahito M，Nobuyuki A，Ayami O，et al.Long term beneficial effects of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker therapy for patient with advanced immunoglobulin A nephropathy and impaired renal function.Clin Exp Nephrol，2011，15：700-707.

29. Xu G，Tu W，Jiang D，et al.Mycophenolate mofetil treatment for IgA nephropathy：a meta-analysis.Am J Nephrol，2008，29：362-367.

30. Tang SC，Tang AW，Wong SS，et al.Long-term study of mycophenolate mofetil treatment in IgA nephropathy.Kidney Int，2010，77（6）：543-549.

31. Wakai K，Kawamura T，Endoh M，et al.A scoring system to predict renal outcome in IgA nephropathy：from a nationwide prospective study. Nephrol Dial Transplant，2006，21，10：2800-2808.

32. Wei BL，Shao SL，Yang LH，et al.Long-term renal survival and related risk factors in patients with IgA nephropathy：results from a cohort of 1155 cases in a Chinese adult population.Nephrol Dial Transplant，2012，27：1479-1485.